Literature DB >> 9794814

Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.

I Björk1, K Nordling, E Raub-Segall, U Hellman, S T Olson.   

Abstract

Cross-class inhibition of cysteine proteinases by serpins differs from serpin inhibition of serine proteinases primarily in that no stable serpin-cysteine proteinase complex can be demonstrated. This difference in reaction mechanism was elucidated by studies of the inactivation of the cysteine proteinases, papain and cathepsin L, by the serpin antithrombin. The two proteinases were inactivated with second-order rate constants of (1.6+/-0.1)x10(3) and (8.6+/-0. 4)x10(2) M-1.s-1 respectively. An antithrombin to papain inactivation stoichiometry of approximately 3 indicated extensive cleavage of the inhibitor concurrent with enzyme inactivation, a behaviour verified by SDS/PAGE. N-terminal sequence analyses showed cleavage predominantly at the P2-P1 bond, but also at the P2'-P3' bond of antithrombin. The papain band in SDS/PAGE progressively disappeared on reaction of the enzyme with increasing amounts of antithrombin, but no band representing a stable antithrombin-papain complex appeared. SDS/PAGE with 125I-labelled papain showed that the disappearance of papain was caused by cleavage of the enzyme into small fragments. These results suggest a mechanism in which papain attacks a peptide bond in the reactive-bond loop of antithrombin adjacent to that involved in serine proteinase inhibition. The reaction proceeds, similarly to that between serpins and serine proteinases, to form an inactive acyl-intermediate complex, although with the substrate pathway dominating in the papain reaction. In this complex, papain is highly susceptible to proteolysis and is degraded by still active papain, which greatly decreases the lifetime of the complex and results in liberation of fragmented, inactive enzyme. This model may have relevance also for the inactivation of physiologically or pathologically important cysteine proteinases by serpins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794814      PMCID: PMC1219835          DOI: 10.1042/bj3350701

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

2.  Routes of thrombin action in the production of proteolytically modified, secondary forms of antithrombin-thrombin complex.

Authors:  W W Fish; K Orre; I Björk
Journal:  Eur J Biochem       Date:  1979-11-01

3.  Release of a two-chain form of antithrombin from the antithrombin-thrombin complex.

Authors:  W W Fish; I Björk
Journal:  Eur J Biochem       Date:  1979-11-01

4.  Molecular weights of protein multimers from polyacrylamide gel electrophoresis.

Authors:  J K Bryan
Journal:  Anal Biochem       Date:  1977-04       Impact factor: 3.365

5.  Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.

Authors:  C Schick; P A Pemberton; G P Shi; Y Kamachi; S Cataltepe; A J Bartuski; E R Gornstein; D Brömme; H A Chapman; G A Silverman
Journal:  Biochemistry       Date:  1998-04-14       Impact factor: 3.162

6.  Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.

Authors:  S T Olson
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

7.  Cloning and expression of the cDNA for human antithrombin III.

Authors:  S C Bock; K L Wion; G A Vehar; R M Lawn
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

8.  Reaction of antithrombin with proteases. Evidence for a specific reaction with papain.

Authors:  A M Valeri; S M Wilson; R D Feinman
Journal:  Biochim Biophys Acta       Date:  1980-08-07

9.  Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group.

Authors:  J R Tchoupe; T Moreau; F Gauthier; J G Bieth
Journal:  Biochim Biophys Acta       Date:  1991-01-08

10.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.

Authors:  J Choay; M Petitou; J C Lormeau; P Sinaÿ; B Casu; G Gatti
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

View more
  8 in total

Review 1.  Evolutionary families of peptidase inhibitors.

Authors:  Neil D Rawlings; Dominic P Tolle; Alan J Barrett
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

2.  Specificity and reactive loop length requirements for crmA inhibition of serine proteases.

Authors:  Lisa D Tesch; Manikanahally P Raghavendra; Tina Bedsted-Faarvang; Peter G W Gettins; Steven T Olson
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

Review 3.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

4.  Preparation and characterization of a truncated caricain lacking 41 residues from the N-terminal.

Authors:  Wei Liu; Wanhui Ye; Zhangming Wang; Honglin Chao; Juyu Lian
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

5.  Structural insights into the unique inhibitory mechanism of the silkworm protease inhibitor serpin18.

Authors:  Peng-Chao Guo; Zhaoming Dong; Ping Zhao; Yan Zhang; Huawei He; Xiang Tan; Weiwei Zhang; Qingyou Xia
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

Review 6.  Enzymes in the time of COVID-19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs.

Authors:  Luana Xavier Soares Gomes Moura Fé; Eliane Pereira Cipolatti; Martina Costa Cerqueira Pinto; Suema Branco; Fábio César Sousa Nogueira; Gisela Maria Dellamora Ortiz; Anderson de Sá Pinheiro; Evelin Andrade Manoel
Journal:  Med Res Rev       Date:  2022-06-28       Impact factor: 12.388

7.  Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.

Authors:  Lukas Wettstein; Patrick Immenschuh; Tatjana Weil; Carina Conzelmann; Yasser Almeida-Hernández; Markus Hoffmann; Amy Kempf; Inga Nehlmeier; Rishikesh Lotke; Moritz Petersen; Steffen Stenger; Frank Kirchhoff; Daniel Sauter; Stefan Pöhlmann; Elsa Sanchez-Garcia; Jan Münch
Journal:  J Med Virol       Date:  2022-09-03       Impact factor: 20.693

8.  Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.

Authors:  Mohamad Aman Jairajpuri; Shoyab Ansari
Journal:  Clin Sci (Lond)       Date:  2020-09-18       Impact factor: 6.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.